Comorbidities in Spondyloarthritis.

about

Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial

P2860

Q57169747-4020F366-CCFE-4BE5-845D-98006EB9C303

P2860

Comorbidities in Spondyloarthritis.

Item

http://www.wikidata.org/entity/Q54246292

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Comorbidities in Spondyloarthritis.

@en

Comorbidities in Spondyloarthritis.

@nl

type

Item

label

Comorbidities in Spondyloarthritis.

@en

Comorbidities in Spondyloarthritis.

@nl

prefLabel

Comorbidities in Spondyloarthritis.

@en

Comorbidities in Spondyloarthritis.

@nl

P1476

Comorbidities in Spondyloarthritis.

@en

P2093

Anna Moltó

http://www.w3.org/2001/XMLSchema#string

Elena Nikiphorou

http://www.w3.org/2001/XMLSchema#string

P2860

Projections of global mortality and burden of disease from 2002 to 2030

Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

Defining comorbidity: implications for understanding health and health services

Inflammation, bone loss and fracture risk in spondyloarthritis

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden.

Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMED.2018.00062

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29594122

http://www.w3.org/2001/XMLSchema#string

P932

5857562

http://www.w3.org/2001/XMLSchema#string

Comorbidities in Spondyloarthritis.

about

P2860

P2860

Comorbidities in Spondyloarthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932